Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Share this article
Open Access Highly Access Research article

Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis

Pei Jin1*, Juan Zhang1, Percy F Sumariwalla2, Irene Ni1, Brett Jorgensen1, Damian Crawford2, Suzanne Phillips3, Marc Feldmann2, H Michael Shepard1 and Ewa M Paleolog2

Author Affiliations

1 Receptor BioLogix, Inc., Palo Alto, CA 94303, USA

2 Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College London, London W6 8LH, UK

3 Gentris Corporation, Morrisville, NC 27560, USA

For all author emails, please log on.

Arthritis Research & Therapy 2008, 10:R73 doi:10.1186/ar2447

Published: 1 July 2008

Additional files

Additional file 1:

A Word file Summarizing the information of the 60 full-length novel splice variants with GenBank accession numbers.

Format: DOC Size: 92KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 2:

A Word file containing a table presenting the cDNA sequences of the 60 full-length novel splice variants that have been deposited with GenBank.

Format: DOC Size: 529KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data